RaQualia Pharma Inc
TSE:4579
RaQualia Pharma Inc
Cash from Investing Activities
RaQualia Pharma Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
RaQualia Pharma Inc
TSE:4579
|
Cash from Investing Activities
-¥135.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Investing Activities
-¥840.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-21%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Investing Activities
-¥201.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Investing Activities
-¥190.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Investing Activities
-¥37.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-11%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Investing Activities
-¥846.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-31%
|
See Also
What is RaQualia Pharma Inc's Cash from Investing Activities?
Cash from Investing Activities
-135.4m
JPY
Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Cash from Investing Activities amounts to -135.4m JPY.
What is RaQualia Pharma Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
18%
Over the last year, the Cash from Investing Activities growth was -184%.